Mice With Mitochondrial Mutation Live Longer, Have Less Fat

If findings of a new study in mice are any indication, it might be possible to fine-tune cellular powerhouses called mitochondria, tweaking one aspect to increase insulin sensitivity, reduce body and fat mass, and even extend life. Exploiting this target could one day lead to novel treatments for type...

Continue Reading...

Oraquick–The Next Step in Testing

What is OraQuick? OraQuick® is the first FDA-approved oral swab in-home test for HIV-1 and HIV-2. It's an oral swab test that doesn't require blood. It's completely private. And it's based on the same HIV test that healthcare professionals have used since 2004. With OraQuick, you have the comfort...

Continue Reading...

Adding dapagliflozin to sulfonylurea improved HbA1c in type 2 diabetes

Results of a phase 3 study presented at the International Diabetes Federation 2011 World Diabetes Congress in Dubai, United Arab Emirates, demonstrate that when added to sulfonylurea therapy, dapagliflozin reduced HbA1c at 24 weeks vs. placebo plus sulfonylurea in patients with type 2 diabetes. The reduction was maintained at 48 weeks, according to a press release. Patients assigned to dapagliflozin...

Continue Reading...

New Tool Saves Time, Reduces Risk of Mistakes in Diabetes Care

In the fast-paced world of health care, doctors are often pressed for time during patient visits. Researchers at the University of Missouri developed a tool that allows doctors to view electronic information about patients' health conditions related to diabetes on a single computer screen. A new study...

Continue Reading...

Hemoglobin A1c Testing Method Fails to Identify Kids With Diabetes, Study Shows

In 2009, the American Diabetes Association (ADA) recommended that Hemoglobin A1c be exclusively used for the diagnosis of diabetes in children. The simple test measures longer-term blood sugar levels -- without requiring patients to fast overnight. However, a new U-M study has shown that these tests...

Continue Reading...